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Abstract
The RNA synthesis machinery of vesicular stomatitis virus (VSV) comprises the genomic RNA encapsidated by the viral
nucleocapsid protein (N) and associated with the RNA dependent RNA polymerase, the viral components of which are a
large protein (L) and an accessory phosphoprotein (P). The 241 kDa L protein contains all the enzymatic activities necessary
for synthesis of the viral mRNAs, including capping, cap methylation and polyadenylation. Those RNA processing reactions
are intimately coordinated with nucleotide polymerization such that failure to cap results in termination of transcription and
failure to methylate can result in hyper polyadenylation. The mRNA processing reactions thus serve as a critical check point
in viral RNA synthesis which may control the synthesis of incorrectly modified RNAs. Here, we report the length at which
viral transcripts first gain access to the capping machinery during synthesis. By reconstitution of transcription in vitro with
highly purified recombinant polymerase and engineered templates in which we omitted sites for incorporation of UTP, we
found that transcripts that were 30-nucleotides in length were uncapped, whereas those that were 31-nucleotides in length
contained a cap structure. The minimal RNA length required for mRNA cap addition was also sufficient for methylation since
the 31-nucleotide long transcripts were methylated at both ribose-29-O and guanine-N-7 positions. This work provides
insights into the spatial relationship between the active sites for the RNA dependent RNA polymerase and
polyribonucleotidyltransferase responsible for capping of the viral RNA. We combine the present findings with our
recently described electron microscopic structure of the VSV polymerase and propose a model of how the spatial
arrangement of the capping activities of L may influence nucleotide polymerization.
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Introduction
The RNA synthesis machinery of the non-segmented negative-
strand (NNS) RNA viruses contains at its core a large polymerase
protein (L) that possesses all the enzymatic activities for genome
transcription and replication. During transcription, L catalyzes
nucleotide polymerization [1–3] as well as each step of mRNA cap
addition [4–9] and polyadenylation [10]. Those activities are
intimately coordinated such that failure to cap the mRNA results
in the premature termination of RNA synthesis [7,11–13], and
failure to methylate the mRNA can result in the hyper
polyadenylation of the mRNA [13–15]. In this study, we sought
to examine how the different L activities are coordinated to ensure
the correct synthesis of a capped and methylated mRNA by
precise determination of the point at which those 59 mRNA
processing reactions occur during transcription.
Our understanding of the activities of L protein has been largely
shaped by studies of a prototype of the NNS RNA viruses,
vesicular stomatitis virus (VSV). The NNS RNA virus L proteins
are homologous and share six regions of sequence conservation
(CRI-VI) [16] that were thought to contain the conserved
functions. The RNA dependent RNA polymerase (RdRP) was
readily identified by the presence of a set of motifs in CRIII [1].
Consistent with this assignment, substitution of an aspartic acid
residue predicted to coordinate a catalytically essential magnesium
ion ablates nucleotide polymerization in vitro. Although L protein
was known to possess the enzymatic activities for mRNA cap
addition, their identity proved difficult to pin down unambigu-
ously. This is because the enzymatic activities themselves are
unusual, in that the cap is added by the action of a
polyribonucleotidyltransferase (PRNTase) that transfers pRNA
onto a GDP acceptor through a covalent L-pRNA intermediate
[7,9,17] This contrasts with all other known capping reactions
which involve an RNA guanylyltransferase that transfers GMP
onto a diphosphate RNA acceptor [18]. Substitutions to residues
in CRV of VSV L that are conserved throughout all NNS RNA
viruses led to the ablation of capping activity in vitro and defined a
motif GxxT[N]HR that was essential for capping, implicating
CRV as the PRNTase [7]. Subsequently, the conserved histidine
was shown to be essential to form the covalent L-pRNA
intermediate, further substantiating this assignment [17]. Poly-
merases that were defective in mRNA cap addition terminated
transcription prematurely, further underscoring the link between
correct 59 mRNA processing and nucleotide polymerization [7].
PLoS Pathogens | www.plospathogens.org 1 June 2011 | Volume 7 | Issue 6 | e1002073Following cap formation, the cap itself is methylated at guanine-
N-7 and ribose-29-O positions [5,19–25]. Those reactions also
differ for VSV since they are catalyzed by a single methyltrans-
ferase domain [8]. Moreover, in contrast to the order of cap
methylation events in other viruses and organisms, the ribose 29-O
methylation precedes and facilitates the subsequent guanine-N-7
methylation [26]. Sequence alignments identified a methylase like
domain in CRVI of L [27,28], and substitutions within this region
block both 29-O and G-N-7 methylation [6,8]. Like capping, the
act of methylation can also influence the properties of the RdRP,
since in some circumstances a failure to methylate the mRNA cap
is accompanied by the production of a large polyadenylate tail by
excessive stuttering of the polymerase on a U7 tract [13–15]. This
intimate co-ordination of the 59 mRNA processing reactions with
nucleotide polymerization may help ensure production of correctly
modified transcripts, which in turn could minimize triggering of
cellular pathways that recognize either uncapped or unmethylated
RNA [29].
Recently, we obtained a first view of the molecular architecture
of the VSV L polymerase protein [30]. Single particle electron
microscopy revealed that the capping machinery of L resides
within 3 globular domains that are appended to a core ring-like
RdRP domain. Moreover the architecture of L rearranges
significantly following complex formation with the essential viral
polymerase cofactor P, and this rearrangement likely positions the
domains in the correct orientation to ensure the modification of
the nascent mRNA chain [30]. In this study, we sought to
determine at what stage a VSV mRNA acquires a cap structure.
Since the PRNTase and the RdRP are localized within different
regions of the L protein, a minimal length of RNA may serve as an
important check point regulating the distinct activities. For
decades RNA synthesis reactions have been carried out in vitro
with VSV using either virus in which the membrane is disrupted
with detergent [31], or purified polymerase (L and P) and the N-
RNA template [32,33]. From those reactions, the shortest
transcripts that were identified as being capped were 37-
nucleotides [34]. It was not clear, however, whether those
transcripts were capped during synthesis or had at some level
gained access to the PRNTase following release from the
polymerase. Recent experiments have shown that short 5-nt
transcripts corresponding to the beginning of a VSV mRNA can
be capped in trans by L, but such experiments cannot address at
what stage during transcription the RNA chain is modified. In the
present study, we established a system to provide a ‘‘freeze-frame’’
view of VSV transcription using templates that lacked sites for
UTP incorporation. By stalling transcription reactions at precisely
defined chain lengths we identify a minimal length at which the
transcript becomes capped. This work reveals the spatial
arrangements of the capping activities of the VSV L protein in
relation to the RNA dependent RNA polymerase domain during
active transcription.
Results
Generation of recombinant viruses to permit stalling of
transcription at specific locations
The promoter for VSV mRNA synthesis includes the 39 leader
region and the first 10-nt of the conserved gene-start element [35–
38]. The sequences of those elements specify the incorporation of
each of the four NTP’s into the nascent RNA chain (Figure 1A),
creating a challenge in selecting a nucleotide that can control
polymerase stalling. We elected to engineer the template such that
it lacked sites for UTP incorporation. We chose UTP because of
the known requirement for a high ATP concentration for initiation
of RNA synthesis, and because previous work had revealed the
essential nature of sites for CTP and GTP incorporation in the cis-
acting signals in the mRNA start sequence [11,39]. To do this, we
engineered the leader region and the gene-start element of a non-
essential 60-nt gene that was inserted at the leader-N gene junction
of an infectious cDNA clone of VSV (Figure 1A). Specifically, we
modified the leader sequence such that it lacked adenosine
nucleotides except for those at position 48–50 which are typically
not transcribed by the polymerase. We generated recombinant
viruses in which those mutations were engineered within the
leader region, purified the virus and confirmed that the mutations
were present in the viral genome (data not shown).
To examine the effect of the leader mutations on viral
transcription, we performed transcription reactions in vitro. Briefly,
10 mg of purified virus was incubated with detergent to disrupt the
viral membrane and NaCl to liberate the M protein from the RNP
core and permit transcription. The detergent-disrupted particles
were incubated in transcription buffer containing ATP, CTP,
UTP and [
32P]-GTP and the products of transcription purified
and analyzed by electrophoresis on acid-agarose gels (Figure 1B).
Although overall levels of transcription were reduced (compare
rVSV (60) and rVSV(A-)60), indicating that the U- leader
promoter was less efficient than the wild type sequence, each of
the viral mRNAs were synthesized. This result demonstrates that
the sequence of the viral leader region could be engineered to
eliminate sites of UTP incorporation which forms the basis of the
templates to stall transcription within the downstream 60-nt
transcriptional unit.
The 60-nt gene sequence was next modified such that the first
place the polymerase would encounter sites for UTP incorpora-
tion were at positions +11–13, 21–23, 31–33, 41–43, or 51–53
with respect to the first gene-start (Figure 2A). Infectious
recombinant VSV was recovered from each of those clones and
while all the mutants grew less well than wild type VSV, there we
no obvious differences in the plaque morphologies of the mutants
(Figure 2B). Sequencing of the genomic RNA confirmed that the
first sites for UTP incorporation were at the desired location
(Figure 2C and data not shown). To determine whether
transcription could be stalled at the inserted adenylates, we used
purified recombinant viruses and performed RNA synthesis in the
absence of UTP. Briefly, 10 mg of purified virus was disrupted
with detergent, incubated in transcription buffer containing ATP,
Author Summary
Using a prototype of the nonsegmented negative strand
RNA viruses, vesicular stomatitis virus, we probed the
spatial relationship between the RNA dependent RNA
polymerase and 59 mRNA capping and methylation
activities of the large polymerase protein. Because the 59
mRNA processing reactions dramatically impact the
nucleotide polymerization activity of the protein, they
may function as a quality control step in viral transcription.
We developed a means to stall transcription at precisely
defined locations following initiation and analyzed the cap
status of the stalled transcripts. We show that 30-nt
transcripts are uncapped whereas those that are 31-nt
long gain are capped and methylated at both guanine-N-7
and ribose-29-O positions. Combined with our recent work
that determined the molecular architecture of the VSV
polymerase, this work reveals the spatial relationship
within a functional polymerase complex of the polymerase
domain and the 59 mRNA processing domains of the L
protein.
Freeze Frame View of VSV Transcription
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32P]-GTP and the products of transcription purified
and analyzed by electrophoresis on polyacrylamide gels. The
VSV recombinants that were designed to stall transcription at
positions +30, 40 and 50, generated RNA of the anticipated
length, thus demonstrating that transcription can be specifically
stalled by omission of UTP from the reactions (Figure 2D). We
did not observe significant quantities of a read-through transcript
where polymerase incorporated another nucleotide in place of
UTP to generate a full-length 60-nt transcript (Figure 2D). This
indicates that the polymerase error rate is insufficient to bypass
three sites of UTP incorporation through mis-incorporation of an
alternate nucleotide.
Treatment of the RNA products with the cap cleaving enzyme
tobacco acid pyrophosphatase (TAP) revealed that the stalled 30-
nt transcript was insensitive to cleavage as evidenced by its
unaltered mobility, whereas the 40-nt and 50-nt transcripts
shifted in mobility by a single nucleotide following cleavage
(Figure 2D). This indicates that the 30-nt transcripts were
uncapped, whereas the 40 and 50-nt long transcripts were
capped. Using a 59-39 exonuclease (+Exo) that cleaves uncapped
RNA, we further confirmed that the 40-nt and 50-nt transcripts
were capped, since those RNAs were resistant to digestion,
whereas the 30-nt transcript was sensitive (Figure 2D). As
expected, each of the recombinant viruses also produced a leader
RNA as evidenced by the collection of transcripts around 47-nt
(Figure 2D). Leader RNA synthesized in vitro is known to contain
at least 4 distinct 39 termini which likely accounts for the multiple
bands observed for the altered leader sequence [40]. Those leader
transcripts lack an mRNA cap structure as shown by their
insensitivity to cleavage by TAP, and their hydrolysis by the 59-to
39 exonuclease. Collectively, this analysis indicates that a VSV
mRNA gains access to the mRNA capping machinery at an RNA
chain length of .30-nt, but ,40-nt. This experiment, however,
could not determine whether the RNA was capped within a
range of 30–40 nt or whether capping required a specific chain
length.
VSV mRNA gains access to the mRNA capping machinery
at a precisely defined nucleotide length
To more precisely define the point at which the RNA chain
gains access to the capping machinery, we constructed a set of
recombinant viruses designed to stall transcription at intermediate
points between 30 and 40-nt (Figure 3A). Specifically, we
recovered viruses designed to stall transcription at 31–37 nts
(Figure 3B) and examined the products made by those viruses
following transcription reactions performed as above. As expected,
each of those viruses generated the characteristic profile of leader
RNAs around 47-nt, as well as specifically stalled transcripts
(Figure 4A). The mobility of the majority of the transcripts
matched the anticipated position of stalling as shown by those
RNAs that were 30, 31, 35, 36 and 37-nt long (Figure 4A). The
mobility difference between the transcripts produced by the viruses
designed to stall transcription at 30 vs. 31-nt appears to be 2-nt,
indicating that the 31-nt transcript was fully capped. By contrast,
stalling appeared relatively inefficient and somewhat heteroge-
neous for the viruses designed to stall transcription at positions +33
and +34 extending from the anticipated length (indicated by the *)
to 1–2 nt larger. Stalling of transcription at +32 appeared
inefficient with only low levels of the stalled transcript visible on
the gel (Figure 4A). An enhanced contrast view of the gel is
provided to illustrate the low levels of stalled transcripts obtained
with the virus designed to stall transcription at +32 (Figure 4A,
lower). Although we do not know the reason for this altered
stalling efficiency it correlates precisely with the point immediately
following mRNA cap addition. The ratio of leader to stalled
transcript appears to vary for several of the recombinant viruses.
Figure 1. Effect of an (A-) leader region on transcription. (A) Schematic of the VSV genome containing an (A-) leader region and a 60-nt long
gene inserted between the leader region and the N gene. The complete sequence of the leader region is shown. The positions at which G residues
were engineered to replace the original A residues in the gene-start sequence are underlined (B) In vitro transcription reactions using 10 mg of each of
the purified viruses were performed in the presence of [a-
32P]-GTP. Purified RNA was analyzed on acid-agarose gel and detected using a
phosphorimager. The identity of the mRNAs is shown on the right.
doi:10.1371/journal.ppat.1002073.g001
Freeze Frame View of VSV Transcription
PLoS Pathogens | www.plospathogens.org 3 June 2011 | Volume 7 | Issue 6 | e1002073Figure 2. Recombinant VSV lacking sites for UTP incorporation permit stalling of transcription. (A) Schematic of the VSV genome
containing an (A-) leader region and a 60-nt long gene inserted between the leader region and the N gene. The complete sequence of the 60-nt gene
is shown, and positions at which G residues were engineered to replace the original A residues in the gene-start sequence are underlined. The sites
(11, 21, 31, 41 and 51) at which 3 sequential adenylates were inserted within the 60-nt gene are indicated together with the anticipated sequence of
the corresponding stalled transcript. (B) The plaque morphology is shown at 48 h postinoculation for rVSV(A-)-10, -20, -30, -40 and -50 and at 24 hpi
for rVSV. (C) A sequence trace of the genomic RNA derived from the 60-nt gene of rVSV(A-)-50 is shown to illustrate the three introduced sites of UTP
Freeze Frame View of VSV Transcription
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of the virus designed to stall transcription at +32, each of the
viruses generated sufficient stalled transcripts for us to determine
the cap status.
To definitively determine whether those transcripts contained
an mRNA cap structure, we compared the mobility of the stalled
transcripts before and after TAP digestion. As expected, the leader
RNA, and the +30 RNA were insensitive to TAP cleavage
indicating that they lack an mRNA cap structure (Figure 4B). By
contrast the transcripts stalled at +31, +35, +36 and +37 showed a
clear single nucleotide shift in their mobility following TAP
cleavage (Figure 4B). Moreover, the collection of transcripts
synthesized following stalling at positions +33 and +34 shifted in
mobility indicating that they were capped (Figure 4B). Collectively,
these data indicate that a VSV mRNA gains access to the capping
machinery at a chain length of 31-nt.
Reconstitution of transcription using a cap-defective
polymerase confirms that the nascent RNA chain gains
access to the capping machinery at +31-nt
The above experiments show that the transcript must be 31-nt
long to be capped. To provide further support for this, we took
advantage of our previously characterized cap defective polymerase
(L-H1227A) [7]. As expected, the transcripts synthesized following
stalling of transcription at +30 were uncapped (Figure 5), and
identical products were generated by L-H1227A. Using wild typeL,
stalling of transcription at position +31 and above demonstrated
that the transcripts were capped. Consistent with this, the cap
Figure 3. Generation and characterization of recombinant VSV. (A) Schematic representation of the genome organization of rVSV(A-)60. The
complete sequence of the 60-nt non-essential gene is shown. The positions (32, 33, 34, 35, 36, 37 and 38) of the introduced UTP incorporation sites in
the 60-nt gene are indicated. The estimated sequences of the different stalled transcripts are shown. (B) Plaque morphology of rVSV(A-)-31. -32, -33,
-34, -35, -36 and -37 is shown at 48 hpi.
doi:10.1371/journal.ppat.1002073.g003
incorporation. (D) The indicated recombinant VSV were used in in vitro transcription (IVT) reaction lacking UTP, but containing [a-
32P]-GTP. The
products of transcription were analyzed on a 6% polyacrylamide gel and visualized using a phosphorimager. Where indicated, the products of
transcription were first digested with tobacco acid pyrophosphatase (TAP) which hydrolyzes the cap-structure, or with an exonuclease (Exo) that
digests uncapped RNA. The identity of the purified viruses used for the IVT reactions are shown at the top of the gel. The uncapped leader RNA and
the 30, 40 and 50-nt long transcripts are indicated. A representative gel of two independent experiments is shown.
doi:10.1371/journal.ppat.1002073.g002
Freeze Frame View of VSV Transcription
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shorter. This experiment confirms the identity of the uncapped
stalled transcripts and further supports that a VSV mRNA gains
access to the mRNA capping machinery at an RNA chain length of
31-nt. We also noted that the cap defective polymerase appears to
stall more readily on the rVSV(A-)32 template. This raises the
possibility that the inability to efficiently stall RNA synthesis reflects
a transition of the polymerase related to cap addition.
Further elongation is not required for cap methylation
Electron microscopic structural analyses of VSV L indicate that
the capping and cap methylation activities reside within distinct
globular domains that are connected to a ring-like domain
containing the RdRP. The capping enzyme resides in a globular
domain that is proximal to the RdRP, whereas the MTase located
to a more distal globular domain. The position of the MTase
domain showed a degree of variability suggesting a high degree of
flexibility within L. Significant structural rearrangements occur in
L, following complex formation with the essential cofactor P
rendering a straightforward identification of the capping and
MTase domains within the active polymerase complex difficult.
We therefore sought to determine whether there was an additional
length requirement for mRNA cap methylation. To do this, we
performed transcription reactions on the engineered templates in
the absence of UTP and the presence of [
3H]-SAM. The resulting
transcripts were purified, analyzed by electrophoresis on a 20%
polyacrylamide gel and detected by fluorography (Figure 6A). The
30-nt uncapped transcripts were not labeled by [
3H]-SAM,
demonstrating that lacked methyl groups at both ribose 29-O
and G-N-7 positions of the cap structure. By contrast the 31-nt
and larger transcripts were labeled by [
3H]-SAM. To evaluate
whether a methyl group was present at both G-N-7 and 29-O
positions, the transcripts were exposed to TAP prior to gel
electrophoresis. Following TAP cleavage, approximately 50% of
the label remained associated with the transcript (Figure 6B),
consistent with the removal of the 7
mGp structure. Because this
reduction in intensity of labeling was apparent starting at the +31
transcript, the results suggest that there is no distinct length
requirement for 29-O and guanine-N-7 methylation. To quantify
this effect further, we measured the amount of label associated
Figure 4. Determination to a single nucleotide the length at
which VSV mRNA gets capped. (A) An autoradiograph of a 6%
polyacrylamide gel is shown indicating the products of the IVT reactions
with recombinant VSV containing a 60-nt long non-essential gene that
lacks sites for UTP incorporation except at positions 31, 32, 33, 34, 35,
36, 37 or 38 respectively. The reaction was performed in the absence of
UTP, but containing [a-
32P]-GTP. The identity of the purified viruses
used for the IVT reactions are shown at the top panel. The uncapped
leader RNA and the different transcripts between 30 and 38 nt are
indicated. Asterisks indicate the 1–2 nt longer than anticipated
transcripts of the rVSV(A-)-33 and -34 viruses. (B) Recombinant VSV(A-)
-30, -31, -33, -34, -35, -36 and -37 were used in in vitro transcription (IVT)
reactions lacking UTP, but containing [a-
32P]-GTP. The products were
analyzed on 6% polyacrylamide gel and visualized using a phosphor-
imager. The products of transcription were either untreated (-) or
digested with TAP (+) which cleaves the cap-structure. The identity if
the purified viruses used for the IVT reactions are shown at the top
panel. The uncapped leader RNA and the different transcripts between
30 and 38 nt are indicated. A representative gel from two independent
experiments is shown.
doi:10.1371/journal.ppat.1002073.g004
Figure 5. Capping occurs at a nascent RNA chain length of 31-
nt. In vitro transcription reactions were reconstituted with 5 mgo fN -
RNA template, 2 mg of purified P, and 4 mg of the indicated L protein in
the absence of UTP, but in the presence of [a-
32P]-GTP. Purified RNA
was analyzed on a 6% polyacrylamide gel and detected using a
phosphorimager. The identity of the template and for the reactions
used polymerase molecules are shown at the top the panel. The
uncapped leader RNA and the different transcripts between 30 and 34
nt are indicated. Asterisks indicate the uncapped transcripts made by
H1227A-L with the different templates. A representative gel from two
independent experiments is shown.
doi:10.1371/journal.ppat.1002073.g005
Freeze Frame View of VSV Transcription
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counting. To eliminate the released 7
mGp we purified RNA that
was longer than 20-nt prior to scintillation counting. This analysis
demonstrates that 50% of the [
3H]-SAM signal is lost upon TAP
cleavage, and indicates that the RNA cap structures are guanine-
N-7 and ribose 29-O methylated. Collectively, these data indicate
that the RNA chain gains access to the MTase domain at the same
length as the PRNTase domain.
Discussion
In this study, we established a freeze-frame approach to stall
VSV transcription using engineered templates that lack sites for
UTP incorporation. Using this approach we defined a nascent
RNA chain length requirement of 31-nucleotide for the access of
the 59 end to the mRNA capping machinery. Since the RNA
chain length for mRNA cap addition is +31-nt and the distance
between adjacent phosphates is approximately 3.4 A ˚, the physical
distance that the nascent RNA chain must transit is approximately
100 A ˚. The requirement for a minimal length for mRNA capping
underscores an architectural arrangement of VSV L where a
defined distance separates the capping domain from the RdRP.
The finding that the capped mRNA does not require further
elongation to be methylated is consistent with a more flexible
positioning of the methyltransferase domain. We discuss the
present observations in light of our earlier work on the molecular
architecture of the VSV polymerase, as well as previous functional
studies of the impact of capping and cap methylation on mRNA
synthesis. Since there are commonalities among the mechanisms
of RNA synthesis, this work also likely has implications for the
large polymerase proteins of other nonsegmented negative-strand
RNA viruses.
Length requirement for mRNA cap addition
The evidence presented here shows that a VSV mRNA must be
31-nt long to gain access to the mRNA capping machinery. This
conclusion comes from stalling transcription at precisely that point
and evaluating whether the RNA contains an mRNA cap
structure. In these experiments, however, the nascent RNA chain
remains stalled at 31-nt and the relative time at which the cap is
added is not certain. Thus while our experiments demonstrate that
the RNA chain can gain access to the PRNTase once it reaches
31-nt, they cannot determine over what range during transcription
cap addition actually occurs. This will be impacted, for example,
by the rate at which the PRNTase catalyzes transfer of the RNA
onto GDP, and indeed the formation of the GDP acceptor.
Consequently, it seems likely that cap addition occurs over a range
of nucleotide positions and that the earliest possible point of
capping is position +31. We and others have reported the existence
of abortive uncapped transcripts that range in size up to several
100 nucleotides [7,11,12]. We anticipate, however, that since
failure to cap leads to premature termination of mRNA synthesis,
it seems likely that capping typically occurs within a short window
of +31. Consistent with this latter idea it is possible to generate a
short capped and polyadenylated transcript from an artificial
transcription unit of 60-nt inserted between the leader and N genes
of VSV [41]. The presence of uncapped transcripts that range in
size up to several 100 nucleotides would then simply reflect the
variable termination of transcripts that failed to gain access to the
capping apparatus within the optimal window for cap addition.
Our study defines the lower limit of that optimal window as 31-nt
during transcription. We do not precisely know the upper limit of
the window for capping nascent RNA, but since we do not observe
large quantities of an uncapped 60-nt mRNA transcript
synthesized in vitro [41] it seems likely that the window is quite
narrow.
The finding that the transcript gains access to the methyltrans-
ferase active site at the same length, +31-nt, demonstrates that
there is no further elongation requirement for cap methylation. An
earlier study that examined the kinetics of mRNA cap methylation
catalyzed by the VSV New Jersey polymerase provided evidence
that cap methylation occurs over a nascent RNA chain length
window that spanned several 100 nucleotides [42]. It seems likely,
therefore, that during transcription the nascent RNA chain
continues to grow while the RNA is being capped and methylated
and that the precise point at which the chain gets methylated is not
critical. Such a scenario therefore implies that the influence of
methylation on mRNA polyadenylation, where failure to methyl-
ate can result in the production of large polyadenylate tails, is
Figure 6. Methylation status of the stalled transcripts. (A) In vitro
transcription reactions were reconstituted with 5 mg of N-RNA template,
2 mg of purified P, and 4 mg of the recombinant L protein in the
absence of UTP, but in the presence of
3H-labeled S-adenosyl-L-
methionine. Purified RNA was analyzed on a 20% polyacrylamide gel
followed by autoradiography. The identity of the template used for the
IVT reactions are shown at the top of the panel. Where indicated, the
products of transcription were digested with tobacco acid pyrophos-
phatase (TAP) which cleaves the cap-structure. The transcripts between
31 and 40-nt are indicated. (B) The autoradiograms from two
independent experiments equivalent to that shown in panel A, were
analyzed by densitometric scanning and the band intensities measured.
A graph showing the % of the total methylated RNA that remains
following TAP cleavage is shown. (C) Total RNA from stalled in vitro
transcription reactions performed in the presence of
3H-SAM was
quantified by scintillation counting before and after TAP cleavage. A
graph showing the % of total radioactivity measured by scintillation
counting following TAP cleavage of the purified RNA is shown.
doi:10.1371/journal.ppat.1002073.g006
Freeze Frame View of VSV Transcription
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act of methylation itself in some way influences the extent of
polymerase stuttering on the U7 tract present at the viral gene-end
sequence and not by influencing the cessation of stuttering during
the reiterative transcription process. The effects of several
mutations in L that ablate mRNA cap methylation were previously
examined for their ability to promote hyper polyadenylation. The
majority of the methylation defective mutants synthesized mRNA
with normal levels of polyadenylate [15]. The synthesis of large
polyadenylate may instead be related to the affinity of the various
L mutants for the inhibitor SAH, such that the hyperpolyadenyla-
tion phenotype may simply reflect increases in the Km for SAM
binding rendering the polymerase mutants hypersensitive to levels
of SAH.
Although the present study defines 31-nt as a minimal length of
mRNA cap addition, it remains possible that there are additional
gene-position or sequence dependent effects that may alter the
precise position of cap addition for specific genes. For example, the
sequence of the transcript may influence the length at which the
RNA gets capped simply by influencing the elongation properties
of the polymerase, or possibly by favoring specific nascent RNA
structures that alter access of the nascent transcript to the capping
site. If such gene specific effects occur, they may serve as a means
to regulate the amount of full-length transcripts made from specific
genes, since failure to cap would lead to premature termination,
down-regulating specific gene expression. We have not yet
succeeded in extending the freeze-frame methodology to study
sequential transcription from the viral genome, consequently,
further experiments will be required to investigate this possibility.
Further insights into the domain organization of the VSV
polymerase
Previous experiments have shown that short exogenous
synthetic RNA oligonucleotides (5–10 nts) are of sufficient length
to be capped when added to VSV L in trans. In the system used in
the current study, where capping is evaluated co-transcriptionally,
mRNAs shorter than 31 nts fail to be capped by the polymerase.
These results indicate that while an exogenously added RNA is
able to freely diffuse into the capping active site, the access of an
endogenous nascent RNA to that site is regulated. Such a
regulation is likely achieved through anchorage of the mRNA 39
end by the RdRP domain preventing the 59 end from accessing a
physically distant capping active site.
In combination with the recent electron microscopic structures,
the present findings provide new insights into the structural and
functional organization of the VSV polymerase. EM images of L
alone showed the organization of L into a ring domain (90–100 A ˚)
containing the RNA polymerase and an appendage of three
globular domains (approximately 45 A ˚ each) containing the cap-
forming activities [30]. The capping enzyme maps to a globular
domain that is juxtaposed to the ring and the cap methyltrans-
ferase maps to one of two more distal and flexibly connected
globules. Notably, the position of the globules relative to one
another appears rather flexible such that the methylase domain
can be positioned adjacent to the RdRP. This arrangement of the
capping and methyltransferase domains is consistent with the
results of this study: the 59 end of the mRNA originating from the
RdRP domain requires a minimal length to reach the capping
apparatus. The length of 100 A ˚ is approximately the distance
spanned by 31 nts, and is consistent with the distance between the
center of the ring and the proximal globular domain in the
appendage. The fact that the same length is sufficient to gain
access to the MTase is consistent with the high degree of flexibility
exhibited by the distal globular domains. However, it should be
emphasized that our EM studies showed that complex formation
with P induces a significant conformational rearrangement of L
including the loss of the globular features of the appendage
(Figure 7). It is this L-P complex that is the active form of the
polymerase for RNA synthesis. The L-P complex, however, retains
some features of the L protein alone, including a ring-like domain
that presumably includes the RdRP activity and an altered
appendage that presumably includes the capping machinery
(Figure 7). The work presented here supports the idea that in
the rearranged appendage, the capping active site is approximately
100A ˚ from the RdRP active site, and the MTase domain is
sufficiently flexible to not require further elongation of the mRNA.
Our findings also have implications for the path the RNA chain
takes between the RdRP domain and the capping apparatus.
Although, the length of the RNA would permit the transcript to
traverse from the core ring domain to the PRNTase appended to
the ring itself, as well as the flexible cap methylation apparatus of
the same L molecule, we cannot exclude the possibility that the
cap formation is catalyzed by an adjacent L molecule. Indeed, our
electron microscopic examination of the L-P complex provided
evidence for polymerase dimers, and genetic experiments with
Sendai virus are consistent with the presence of at least a dimeric
polymerase complex. It remains unknown, however, whether cap
defective VSV polymerase molecules can complement RdRP
defective VSV polymerase molecules. If indeed the RNA chain is
capped by an adjacent polymerase molecule, such complementa-
tion should be achievable. Additionally, by incorporation of thio
substituted nucleotides within the nascent RNA chain, it should
now be possible to decipher the path that the RNA chain traverses
in its transit from the RdRP domain to the PRNTase domain.
Influence of capping events on nucleotide
polymerization
During transcription, the capping activities of L are known from
biochemical experiments to influence the polymerization activity.
Specifically, failure to cap the mRNA leads to premature
termination of transcription [7,11–13], and inhibition of methyl-
Figure 7. A schematic of the architecture of the VSV poly-
merase. A schematic depicting the arrangement of the various
domains of VSV L is shown based upon electron microscopic analysis
of single L protein molecules (left), along with the rearrangements that
occur on complex formation with the cofactor P (right) [30]. The
positions of flexibility within the L alone structure are depicted by
arrows. The approximate dimensions of the protein are shown in
angstroms (A ˚).
doi:10.1371/journal.ppat.1002073.g007
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We previously investigated the influence of sequence on premature
termination by polymerases that are defective in cap addition [13].
Analogous to authentic termination, premature termination was
favored at AU rich elements in the template and was significantly
suppressed during copying of CG rich templates. This implies that
the strength of a hybrid between the nascent strand and template
can influence polymerase processivity. Although speculative, a
relatively simple mechanism by which capping could influence
termination is by regulating the stability of the hybrid between the
nascent strand and template in the RdRP domain. Since the
capping domain is juxtaposed to the ring, capping itself may
induce a tightening of the grip of the polymerase stabilizing the
hybrid between the template and nascent mRNA strand thus
rendering the polymerase fully processive. The physical seques-
tration of the 59 end of the nascent RNA strand within the
PRNTase domain and then the cap methylation domain may itself
also favor the RNA polymerization reaction becoming fully
processive, so that the nascent RNA chain has elongated to the
point at which the polymerase can only terminate in response to a
highly specialized transcription stop sequence.
The length requirement for mRNA 59 modification is similar to
that previously reported for vaccinia virus [43], RNA polymerase
II and the apparent length at which a reovirus transcript gains
access to the capping enzyme [44]. In those other cases the
capping enzyme is encoded by a separate polypeptide that appears
associated with the RNA polymerase either physically in the case
of the reovirus polymerase as a structural component of the virus
capsid, or by recruitment to the phosphorylated C-terminal
domain of RNA polymerase II [45]. For RNA polymerase II it has
been shown that the nascent RNA chain is capped over a range of
nucleotide positions, in this case the polymerase pauses prior to the
act of mRNA cap addition, and the act of cap addition is linked to
full polymerase elongation. We do not know whether a similar
pausing event occurs during VSV transcription. The properties of
the polymerase, however, do appear distinct immediately upon
cap addition. This is illustrated by the fact that while we were able
to efficiently stall the polymerase at positions +30, +31, +35, +36,
+37, +40, +50 during transcription, stalling at positions +32, +33
and +34 result in a ladder of products that range up to 1–2
nucleotides longer than anticipated. Since the cap was just added
at position +31, capping itself may render the polymerase
somewhat resistant to stalling and result in the production of
slightly longer transcripts.
A second possible explanation for the production of stalled
transcripts that vary in their precise point of termination relates to
the intrinsic ability of the polymerase to stutter on homopolymeric
tracts. The best characterized slippage sequence for VSV is that of
the gene-end AUACUUUUUUUG in which the AUAC element
regulates the extent of stuttering by L on the U7 tract [46]. We
considered that the template sequence CCGUUUGUCUUU
present at positions 25–36 of the unperturbed 60-nt gene may itself
favor some slippage that is enhanced by the insertion of three
adenylates at positions 32, 33, and 34. Although the presence of G
or C within a U tract blocks slippage during transit of polymerase
across a gene-junction [46], the general A/U rich nature of the
present sequence may be sufficient to destabilize the elongating
polymerase complex in vitro. Definitive assessment of the precise
point of termination of the stalled transcripts will require
sequencing of these small RNA products.
Implications of freeze-frame studies of VSV transcription
The ability to stall transcription at specific places on the
template, through the use of engineered recombinant templates
now provides us an ability to study more precisely the steps of
transcription. This methodology should be readily adaptable to
probe the length of the nascent RNA chain that is protected by the
polymerase during transcription and to determine whether the
RNA chain becomes accessible prior to mRNA cap addition.
Moreover, combined with our ability to image the L-P complex by
electron microscopy, this approach may permit us to examine the
polymerase bound to the RNA template at various stages of
transcription. Our work also has implications for understanding
transcription in other nonsegmented negative-strand RNA viruses
in that they likely require a minimal length of transcription prior to
cap addition. We anticipate that those lengths will vary for each
virus, and as outlined above may perhaps show gene-specific
variation. Since the production of triphoshphate RNA itself may
serve as an activator of specific cytosolic sensors of the innate
immune system, what appears to be a specific and efficient position
of mRNA cap addition may also serve to decrease the production
of pppRNA transcripts in infected cells. Moreover, since the act of
capping serves as a positive regulator of transcriptional elongation
this minimal length represents a key check-point in the
transcription cycle.
Materials and Methods
Generation of recombinant viruses
Plasmid pVSV1(+)60, containing an infectious cDNA clone of
the VSV genome with a 60-nt long non-essential gene inserted at
the leader-N gene junction, was generated as described previously
[41]. The adenylates at positions 19, 20, 22, 23, 25, 28, 29 and 37-
nt in the VSV genome were replaced using site-directed
mutagenesis to generate an (A-) leader region (Figure 1A). In
order to introduce three adenylates at positions 11, 21, 31, 32, 33,
34, 35, 36, 37, 38, 41 and 51 in the 60-nt long non-essential gene
site-directed mutagenesis was performed. The presence of the
mutation was confirmed by sequence analysis. Recombinant VSV
was rescued from cDNA by transfection of BHK-21 cells infected
with a recombinant vaccinia virus (vTF7-3) that expressed T7
RNA polymerase as described previously [47,48]. The generated
viruses were designated rVSV(A-)-10, -20, -30, -31, -32, -33, -34, -
35, -36, -37, -40 and -50, respectively. Cell culture supernatants
were collected at 48 to 96 h post transfection, and virus was
amplified once in BHK-21 cells. Individual plaques were isolated
on Vero cells, and large stocks were generated in BHK-21 cells
and purified as described previously [12]. Viral titer was
determined by plaque assay on Vero cells, and protein content
was measured with the Bradford reagent (Sigma Chemical Co., St
Louis, MO). The (A-) leader and 60-nt gene of the purified viruses
were sequenced again, and these stocks were used for in vitro
transcription reactions.
Transcription and analysis of viral RNA
Viral RNA was synthesized in vitro as described previously
[31,38]. 10 mg of the purified recombinant virus was activated by
incubation with detergent for 5 min at room temperature. RNA
synthesis reactions were performed in the presence of nucleotide
triphosphates (1 mM ATP and 0.5 mM each of CTP and GTP).
The reaction mixtures were supplemented with 20 mmCi of
[a-
32P]-GTP (3,000 Ci mmol
-1) (Perkin-Elmer, Wellesley, MA).
Total RNA was extracted, purified, and used for secondary
manipulations as follows. Where indicated, the RNA cap structure
was removed by tobacco acid pyrophosphatase (TAP; Epicenter)
as previously described [6]. For exonuclease digestion, total RNA
was dephosphorylated using Antarctic phosphatase (New England
Biolabs [NEB]), and a single phosphate was added using T4
Freeze Frame View of VSV Transcription
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instructions. The resulting RNAs were subsequently treated with
Terminator exonuclease (Epicenter) according to the manufactur-
er’s instructions [12]. The products of RNA synthesis were
analyzed on a 6% polyacrylamide gel and visualized by a
phosphorimager (GE Healthcare; Typhoon).
N-RNA template purification
The N-RNA template was purified from rVSV(A-)-30, -31, -32
and-33 as described previously [6]. Briefly, 4 mg purified virus was
disrupted on ice for 1 h in 20 mM Tris-HCl (pH 8.0), 0.1%
Triton X-100, 5% glycerol, 5 mM EDTA, 3.5 mM dithioery-
thritol, 20% dimethyl sulfoxide, and 1.0 M LiCl. The template
was recovered by centrifugation (190,0006g, 3.5 h) through a step
gradient of 0.25 ml each of 40, 45, and 50% glycerol in TED
buffer (20 mM Tris-Cl [pH 8.0], 1 mM EDTA, 2 mM dithioer-
ythritol) supplemented with 0.1 M NaCl. The pellet was
resuspended in 0.3 ml of TED buffer plus 10% glycerol and
disrupted on ice, except that the Triton X-100 and EDTA
concentrations were reduced to 0.05% and 1 mM, respectively.
The N RNA was isolated by banding in a 3.6-ml 20 to 40% (wt/
wt) CsCl gradient (150,0006g, 2.5 h), recovered by side puncture
and diluted fourfold with 10 mM Tris-Cl (pH 8.0), 0.1 mM
EDTA. The N-RNA was recovered following centrifugation
(150,0006 g, 1.5 h) through a 0.5-ml cushion (50% glycerol,
TED buffer, 0.1 M NaCl).
Expression and purification of recombinant VSV
polymerase
Recombinant L was expressed from recombinant baculoviruses
in Spodoptera frugiperda 21 cells, and P was expressed in BL21 (DE3)
as described previously [6]. At 72 h postinfection, the cells were
collected, washed twice with ice-cold phosphate-buffered saline,
and recovered by centrifugation. The cells were suspended in lysis
buffer (50 mM NaH2PO4, 10% glycerol, 0.2% NP-40, 300 mM
NaCl, 10 mM imidazole [pH 8.0]) supplemented with EDTA-free
protease inhibitor cocktail (Roche) and 1 mM phenylmethylsulfo-
nyl fluoride and disrupted by sonication. The L and P proteins
were purified by Ni-nitrilotriacetic acid–agarose (Qiagen), fol-
lowed by ion-exchange chromatography as described previously
[6].
Reconstitution of viral RNA synthesis in vitro
Reactions were carried out in the absence of rabbit reticulocyte
lysate using 5 mg of N-RNA template, 4 mg of purified L, 2 mgo f
purified P and nucleoside triphosphates (1 mM ATP and 0.5 mM
each of CTP and GTP) as described previously [6]. The reaction
mixtures were supplemented with 20 mCi of [a-
32P]GTP (3,000 Ci
mmol
21) (Perkin-Elmer, Wellesley, MA). After 5 h of incubation at
30uC, the RNA was purified by phenol and chloroform extraction
and analyzed on 6% polyacrylamide gel and visualized by a
phosphorimager (GE Healthcare; Typhoon). For methylation of
the transcripts, the same reaction condition was used as described
above with the exception that 20 mM
3H-labeled S-adenosyl-L-
methionine (
3H-SAM) (76 Ci/mmol, Perkin-Elmer, Wellesley,
MA) was used for labeling the RNA instead of [a-
32P]GTP. After
5 h of incubation at 30uC, the RNA was purified by phenol and
chloroform extraction and analyzed on 20% polyacrylamide gel
followed by autoradiography.
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